Teleconference: Lysosomal Storage Diseases – Report from LDN WORLD Symposium (11:00 AM EST)

Time & Location

Originally Presented: February 12, 2010 11:00 AM, Teleconference

Presenter(s):

GLG Expert Contributor

Agenda:

  • What does a six month delay mean for Protalix’s Uplyso?
  • Impact of FDA approval of Shire’s velaglucerase alfa and Protalix BioTherapeutics’ prGCD on Genzyme’s market share in Gaucher’s disease—Who will win?
  • Outlook for Genzyme’s Cerezyme: Is competition coming?
  • Will Shire be able to meet the anticipated global demand of REPLAGAL and steal market share from Genzyme’s Fabrazyme or will this be an opportunity lost? For those unable to attend this teleconference at its scheduled time, an audio replay may be available within 24 hours. Alternatively, a transcript may be available for purchase beginning on Wednesday, March 3. For further information, please click here.

View Webcasts & Teleconferences in Healthcare

View All Webcasts & Teleconferences in Healthcare

About GLG Live Meetings

A program focused on educating business and investment professionals through seminars on current trends and core concepts in various industries. Detailed workbooks distributed at the Seminars provide educational reference materials for later review. GLG Live Meetings enable clients to increase thier own industry education by proposing new seminar topics or adding agenda terms to currently scheduled seminars.